These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35016848)

  • 1. ASPER-29 suppresses the metastasis of pancreatic cancer cells by dual inhibition of cathepsin-L and cathepsin-S.
    Yuan L; Zhao J; Zhao S; Dong T; Dong R; Liu D; Ma E; Li Y
    Chem Biol Interact; 2022 Feb; 353():109811. PubMed ID: 35016848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of dual cathepsin L and S inhibitors and antimetastatic activity evaluation in pancreatic cancer cells.
    Huang H; Zhang Y; Xu X; Liu Y; Zhao J; Ma L; Lei J; Ge W; Li N; Ma E; Li Y; Yuan L
    Bioorg Med Chem Lett; 2023 Jan; 80():129087. PubMed ID: 36427655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel cathepsin inhibitors with potent anti-metastatic effects in breast cancer cells.
    Yuan L; Sheng L; He W; Zou C; Hu B; Liu J; Ge W; Liu Y; Wang J; Ma E
    Bioorg Chem; 2018 Dec; 81():672-680. PubMed ID: 30253340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a novel cathepsin inhibitor with dual autophagy-inducing and metastasis-inhibiting effects on breast cancer cells.
    Yuan L; Liu J; He W; Bao Y; Sheng L; Zou C; Hu B; Ge W; Liu Y; Wang J; Lin B; Li Y; Ma E
    Bioorg Chem; 2019 Mar; 84():239-253. PubMed ID: 30503850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a novel and selective cathepsin L inhibitor with anti-metastatic ability in vitro and in vivo against breast cancer cells.
    Li Y; Ai X; Zou C; Liu Y; Ma L; Men J; Liu D; Sheng L; Ruan X; Liu H; Li W; Ma E; Yuan L
    Bioorg Chem; 2021 Oct; 115():105256. PubMed ID: 34426153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biochemical evaluation of benzoylbenzophenone thiosemicarbazone analogues as potent and selective inhibitors of cathepsin L.
    Parker EN; Song J; Kishore Kumar GD; Odutola SO; Chavarria GE; Charlton-Sevcik AK; Strecker TE; Barnes AL; Sudhan DR; Wittenborn TR; Siemann DW; Horsman MR; Chaplin DJ; Trawick ML; Pinney KG
    Bioorg Med Chem; 2015 Nov; 23(21):6974-92. PubMed ID: 26462052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of catalase on migration and invasion of lung cancer cells by regulating the activities of cathepsin S, L, and K.
    Tsai JY; Lee MJ; Dah-Tsyr Chang M; Huang H
    Exp Cell Res; 2014 Apr; 323(1):28-40. PubMed ID: 24583396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of novel human cathepsin S inhibitors on cell migration in human cancer cells.
    Tsai JY; Lee MJ; Chang MD; Wang HC; Lin CC; Huang H
    J Enzyme Inhib Med Chem; 2014 Aug; 29(4):538-46. PubMed ID: 24083411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and pre-clinical testing of a reversible cathepsin protease inhibitor reveals anti-tumor efficacy in a pancreatic cancer model.
    Elie BT; Gocheva V; Shree T; Dalrymple SA; Holsinger LJ; Joyce JA
    Biochimie; 2010 Nov; 92(11):1618-24. PubMed ID: 20447439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SAR studies of some acetophenone phenylhydrazone based pyrazole derivatives as anticathepsin agents.
    Raghav N; Singh M
    Bioorg Chem; 2017 Dec; 75():38-49. PubMed ID: 28915464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential cathepsin responses to inhibitor-induced feedback: E-64 and cystatin C elevate active cathepsin S and suppress active cathepsin L in breast cancer cells.
    Wilder CL; Walton C; Watson V; Stewart FAA; Johnson J; Peyton SR; Payne CK; Odero-Marah V; Platt MO
    Int J Biochem Cell Biol; 2016 Oct; 79():199-208. PubMed ID: 27592448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CT109-SN-38, a Novel Antibody-drug Conjugate with Dual Specificity for CEACAM5 and 6, Elicits Potent Killing of Pancreatic Cancer Cells.
    Cardenas KCA; Enos CW; Spear MR; Austin DE; Almofeez R; Kortchak S; Pincus L; Guo HB; Dolezal S; Pierce JM; Furth E; Gineste C; Kwon Y; Gelber C
    Curr Cancer Drug Targets; 2024; 24(7):720-732. PubMed ID: 38178674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MIF inhibitor, ISO-1, attenuates human pancreatic cancer cell proliferation, migration and invasion in vitro, and suppresses xenograft tumour growth in vivo.
    Cheng B; Wang Q; Song Y; Liu Y; Liu Y; Yang S; Li D; Zhang Y; Zhu C
    Sci Rep; 2020 Apr; 10(1):6741. PubMed ID: 32317702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rasfonin, a novel 2-pyrone derivative, induces ras-mutated Panc-1 pancreatic tumor cell death in nude mice.
    Xiao Z; Li L; Li Y; Zhou W; Cheng J; Liu F; Zheng P; Zhang Y; Che Y
    Cell Death Dis; 2014 May; 5(5):e1241. PubMed ID: 24853419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cathepsin inhibition-induced lysosomal dysfunction enhances pancreatic beta-cell apoptosis in high glucose.
    Jung M; Lee J; Seo HY; Lim JS; Kim EK
    PLoS One; 2015; 10(1):e0116972. PubMed ID: 25625842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2,5-Diaryloxadiazoles and their precursors as novel inhibitors of cathepsins B, H and L.
    Garg S; Raghav N
    Bioorg Chem; 2016 Aug; 67():64-74. PubMed ID: 27285276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cathepsin L inhibition suppresses drug resistance in vitro and in vivo: a putative mechanism.
    Zheng X; Chu F; Chou PM; Gallati C; Dier U; Mirkin BL; Mousa SA; Rebbaa A
    Am J Physiol Cell Physiol; 2009 Jan; 296(1):C65-74. PubMed ID: 18971393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinazoline derivatives as cathepsins B, H and L inhibitors and cell proliferating agents.
    Raghav N; Jangra S; Kumar A; Bhattacharyya S
    Int J Biol Macromol; 2017 Jan; 94(Pt A):719-727. PubMed ID: 27780761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fsn0503h antibody-mediated blockade of cathepsin S as a potential therapeutic strategy for the treatment of solid tumors.
    Vázquez R; Astorgues-Xerri L; Bekradda M; Gormley J; Buick R; Kerr P; Cvitkovic E; Raymond E; D'Incalci M; Frapolli R; Riveiro ME
    Biochimie; 2015 Jan; 108():101-7. PubMed ID: 25446656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azepanone-based inhibitors of human cathepsin S: optimization of selectivity via the P2 substituent.
    Kerns JK; Nie H; Bondinell W; Widdowson KL; Yamashita DS; Rahman A; Podolin PL; Carpenter DC; Jin Q; Riflade B; Dong X; Nevins N; Keller PM; Mitchell L; Tomaszek T
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4409-15. PubMed ID: 21733692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.